Effect of HIV-1 infection and increasing immunosuppression on menstrual function

Journal of Obstetrics and Gynaecology Research

Volumn 36, Issue 5, 2010, Pages 1053-1058

  Ezechi, Oliver C ^a   Jogo, Andrea ^b   Gab Okafor, Chidinma ^a   Onwujekwe, Dan I ^c   Ezeobi, Paschal M ^c   Gbajabiamila, Titi ^c   Adu, Rosemary A ^c   Audu, Rosemary A ^d   Musa, Adesola Z ^c   Salu, Olumuyiwa B ^d   Meschack, Emily ^d   Herbertson, Ebiere ^c   Odunukwe, Nkiru ^c   Idigbe, Oni E ^c  

^a Sexual and Reproductive Health Research Unit   (United Kingdom)

^b FEDERAL MEDICAL CENTER   (Nigeria)

^c Clinical Sciences Division   (United Kingdom)

^d NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

Author keywords

antiretroviral drug; HIV AIDS; immunosuppression; menstrual abnormality

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AMENORRHEA; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; COITUS; CONTROLLED STUDY; DYSMENORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERMENORRHEA; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MENORRHAGIA; MENSTRUAL IRREGULARITY; MENSTRUATION; MENSTRUATION DISORDER; NIGERIA; OLIGOMENORRHEA; OPPORTUNISTIC INFECTION; POSTCOITAL BLEEDING; PREVALENCE;

ADOLESCENT; ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; IMMUNOSUPPRESSION; MENSTRUATION DISTURBANCES; NIGERIA; ODDS RATIO; PREVALENCE; RISK FACTORS;

EID: 77957555821     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01253.x     Document Type: Article

References (22)

1. Ezechi OC, Jogo AA, Njemanze O et al. Effect of HIV-1 infection and increasing immunosuppression on menstrual function. Fourth IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, abstract MOPDB02, 2007.
2. Harlow SD, Schumann P, Cohen M et al. Effect of HIV infection on menstrual cycle length. J Acquir Immune Defic Syndr 2000 24 : 68 75.
3. Valimaki M, Pelkonene R, Salaspuro M, Harkonen M, Hirvonen E, Ylikahri R. Sex hormones in amenorrheic women with alcoholic liver disease. J Clin Endocrinol Metab 1984 59 : 133 138.
4. Knuth UA, Hull MGR, Jacobs HS. Amenorrhea and loss of weight. Br J Obstet Gynaecol 1977 84 : 801 807.
5. Warne PA, Ehrhardt A, Schechter D, Williams J, Gorman J. Menstrual abnormalities in HIV+ and HIV- women with a history of intravenous drug use [abstract M. C. 311]. Presented at the VII International Conference on AIDS, Florence, Italy, 1991.
6. Muggiasca ML, Agarossi A, Ghetti E, Ravasi L, Federici D, Conti M. Gynecological problems in HIV-positive women [abstract POB23-1941]. Presented at the IX International Conference on AIDS, Berlin, Germany, 1993.
7. Cohen M, Greenblatt R, Minkoff H et al. Menstrual abnormalities in women with HIV infection [abstract Mo. B. 540]. Presented at the XI International AIDS Conference, Vancouver, 1996.
8. Chirgwin KD, Feldman F, Muneyyirci-Delale O. Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome. J Acquir Immunodefic Syndr Hum Retrovirol 1996 12 : 489 494.
9. Massad SL, Evans CT, Minkoff H et al. Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women. J Womens Health 2006 15 : 591 598.
10. Ellerbrock TV, Wright TC, Bush TJ, Dole P, Brudney K, Chiasson MA. Characteristics of menstruation in women infected with human immunodeficiency virus. Obstet Gynecol 1996 87 : 1030 1034. (Pubitemid 26159405)
11. Shah PN, Smith JR, Wells C, Barton SE, Kitchen VS, Steer PJ. Menstrual symptoms in women infected by the human immunodeficiency virus. Obstet Gynecol 1994 83 : 397 400.
12. Olusanya O, Okpere E, Ezimokhai M. The importance of social class system in voluntary fertility control in a developing country. West Afr J Med 1985 4 : 205 212.
13. Idigbe OE, Adewole TA, Eisen G et al. Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine. A preliminary report on the Nigerian Antiretroviral Program. J Acquir Immune Defic Syndr 2005 40 : 65 69.
14. U.S. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. 1995 7 : 1 34.
15. Harlow SD, Ephross SA. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev 1995 17 : 265 286.
16. Toriola AL, Mathur DN. Menstrual function in Nigeria athletes. BJOG 1986 93 : 979 985.
17. Lynda L, Siobán DH, Xihong L, Brenda G, Mary F. Sowers: sampling strategies for prospective studies of menstrual function. Am J Epidemiol 2004 159 : 795 802.
18. Lo JC, Schambelan M. Reproductive function in human immunodeficiency virus infection. J Clin Endocrinol Metab 2001 86 : 2338 2344.
19. Chirgwin KD, Feldman J, Muneyyirci-Delale O, Landesman S, Minkoff H. Menstrual function in human immunodeficiency virus-infected women without acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr Hum Retrovirol 1996 12 : 489 494.
20. Croxson TS, Chapman WE, Miller LK, Levit CD, Senie R, Zumoff B. Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men. J Clin Endocrinol Metab 1989 68 : 317 321.
21. Laudat A, Blum L, Guechot J. Changes in systemic gonadal and adrenal steroids in asymptomatic human immunodeficiency virus-infected men: relationship with the CD4 cell counts. Eur J Endocrinol 1995 133 : 418 424.
22. Merenich JA, McDermott MT, Asp AA, Harrison SM, Kidd GS. Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab 1990 70 : 566 571.